Research Article Association between Glycemic Control and Clinic Attendance in Emerging Adults with Type 1 Diabetes: A Tertiary Center Experience Eldad Fisher, 1 Liora Lazar, 1,2 Shlomit Shalitin, 1,2 Michal Yackobovitch-Gavan, 2 Liat de Vries, 1,2 Tal Oron, 2 Ariel Tenenbaum, 1,2 Moshe Phillip, 1,2 and Yael Lebenthal 1,2 1 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel 2 The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva 49202, Israel Correspondence should be addressed to Yael Lebenthal; yael.lebenthal@gmail.com Received 13 March 2018; Revised 21 May 2018; Accepted 19 June 2018; Published 9 July 2018 Academic Editor: Andrea Scaramuzza Copyright © 2018 Eldad Fisher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Aims. The transition of emerging adults with type 1 diabetes (T1D) from pediatric diabetes clinics to adult clinics between 18 and 21 years of age could result in decreased clinic attendance and thus worsen glycemic control. Our institutional policy offering surveillance till age 30 enabled us to evaluate clinic attendance without the confounding effect of transition. Our aim was to determine the association between glycemic control (HbA1c) and attendance rate. Methods. The medical records of 261 (54% males) young adult T1D patients (median age 22.9 years) were reviewed. Patients were stratified according to the attainment/ nonattainment of glycemic targets (HbA1c ≤ 7% versus HbA1c > 7% (53 mmol/mol)). The attendance rate was calculated as the number of clinic visits/number of scheduled appointments. Results. Median annual number of scheduled visits was 3 (3, 4); attendance rate was 75% (53.6%, 100%). Seventy-four (28.4%) patients attained glycemic targets (median HbA1c 6.5% (48 mmol/mol) (6.3%, 6.8% (45.51 mmol/mol)); 187 (71.6%) patients had a median HbA1c of 7.8% (62 mmol/mol) (7.4%, 8.4% (57.68 mmol/mol)). The attainment of the treatment target was more prevalent in older patients (P =0 006), in male patients (P =0 007), and in patients with higher education (P =0 017). Higher attendance rate (β (2.483), P <0 001) and male gender (β (0.746), P =0 015) were associated with better metabolic control. Conclusions. In emerging adults with T1D during the ongoing stable phase of diabetes management, higher attendance rate, rather than absolute number of clinic visits, was associated with the attainment of glycemic targets. 1. Introduction The Diabetes Control and Complications Trial (DCCT), based on a regimen of monthly clinic visits with a multi- disciplinary team, clearly demonstrated the positive impact of intensive diabetes therapy on glycemic control [1]. Since then, it has come to be widely accepted that the more practical regimen of 3-4 annual visits, as advocated by the American Diabetes Association (ADA), constitutes a satis- factory therapeutic regimen for adults with T1D [2, 3]. The routine clinical practice followed for young adults in our tertiary center for diabetes has been quarterly clinical visits during which HbA1c is evaluated and diabetes management is reassessed. Yet, diabetologists can recommend a fewer or greater number of visits per their clinical judgement [3]. T1D patients who have unsatisfactory glycemic control are invited more frequently in an attempt to promote adherence to treatment regimen. Emerging adulthood (defined as age 18–30 years) is a period when patients are expected to assume greater respon- sibility for their diabetes care, while parents reduce their involvement in management of the disease [4]. Current guidelines endorse the transition of T1D patients from pedi- atric diabetes clinics to adult clinics between 18 and 21 years Hindawi Journal of Diabetes Research Volume 2018, Article ID 9572817, 6 pages https://doi.org/10.1155/2018/9572817